1Zhou X, Wang H, Shi P, et al. Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed en- zyme prodrug therapy[J]. Onco Targets Ther, 2014, 10(7): 535- 541.
2Schellmann N, Deckert PM, Bachran D, et al. Targeted enzyme prodrug therapies[J]. Mini Rev Med Chem,2010,10(10):887-904.
4Harding .1, Burtness B. Cetuximab: an epidermal growth factor re- ceptor chemeric human-murine monoclonal antibody[J]. Drugs To- day (Barc),2005,41 (2) : 107-127.
5Bhuvaneswari R, Gan YY, Soo KC, et al. Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response[J]. Mol Cancer, 2009,8:94. doi: 10.1186/ 1476-4598-8-94.
6Dhomen NS, Mariadasan J, Tebbutt N, et al. Therapeutic targeting of the epidermal growth factor receptor in human cancer[J]. Crit Rev Oncog,2012,17( 1 ) :31-50.
